Aichi Prefecture
Records under this name other than the patents Aichi Prefecture holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,828,377 | Method for Determining Presence or Absence of Suffering from Malignant Lymphoma or Leukemia, and Agent for Treatment And/Or Prevention of Leukemia Formerly held Lapsed on the fee record Ended Nov 10, 2024 · High confidence | Lapsed on the fee record | Ended Nov 10, 2024 | High confidence |
| US 7,846,651 | Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same Lapsed on the fee record Ended Dec 7, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 7, 2022 | From the USPTO record |
| US 10,022,659 | Device for isolating periphery circulating tumor cells or rare cells, and method of isolating periphery circulating tumor cells or rare cells Lapsed on the fee record Ended Jul 17, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 17, 2022 | From the USPTO record |
| US 7,619,058 | Epitope/Peptide Recognized by HLA-A2402-Restricted Ep-Cam-Specific CTL and Use of the Same Lapsed on the fee record Ended Nov 17, 2021 · High confidence | Lapsed on the fee record | Ended Nov 17, 2021 | High confidence |
| US 8,481,051 | Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof Lapsed on the fee record Ended Jul 9, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 9, 2021 | From the USPTO record |
| US 7,423,126 | Antibody that reacts with 6-sulfated sialyl Lewis X Term ended Term ended Feb 25, 2020 · From the USPTO record | Term ended | Term ended Feb 25, 2020 | From the USPTO record |
| US 7,935,792 | Antibody reacting with N-acetylglucosamine-6-O-sulfotransferase product Lapsed on the fee record Ended May 3, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 3, 2019 | From the USPTO record |
| US 7,856,318 | Method of classifying gene expression strength in lung cancer tissues Formerly held Lapsed on the fee record Ended Dec 21, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 21, 2018 | From the USPTO record |
| US 8,865,775 | Anti-inflammatory agent and cancer-preventive agent comprising canolol or prodrug thereof and pharmaceutical, cosmetic and food comprising the same Formerly held Lapsed on the fee record Ended Oct 21, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 21, 2018 | From the USPTO record |
| US 8,244,478 | Method of classifying gene expression strength in lung cancer tissues Lapsed on the fee record Ended Aug 14, 2016 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2016 | From the USPTO record |